Böbrek Kanserinde Mikrodalga Ablasyon
Özet
Küçük renal kitlelerin (KRK) tedavisinde termal ablasyon yöntemleri giderek daha fazla tercih edilmektedir. Geleneksel yöntemler olan radyofrekans ablasyon (RFA) ve kriyoablasyonun (KA) 3-4 cm'den büyük tümörlerde etkinliği sınırlıyken, yeni bir teknik olan mikrodalga ablasyon (MDA) bu noktada öne çıkmaktadır. MDA, 900 MHz ve üzeri frekanslar kullanarak su moleküllerini çalkalamakta, sürtünme ve ısı yoluyla pıhtılaşma nekrozu oluşturarak hücresel ölüme yol açmaktadır. Bu yöntem; daha yüksek intratümöral sıcaklıklar, daha geniş ablasyon hacimleri, daha hızlı işlem süreleri ve perfüzyon aracılı ısı emici etkiden daha az etkilenme gibi teorik avantajlar sunar. Klinik ve ön çalışmalar, MDA'nın evre T1a ve T1b tümörlerde, ayrıca soliter böbrekli hastalarda güvenli ve etkili bir alternatif olduğunu ortaya koymaktadır. Radikal veya parsiyel nefrektomi gibi cerrahi yöntemlerle karşılaştırıldığında, MDA'nın benzer onkolojik sonuçlar sağladığı, buna karşın daha az kan kaybı, daha kısa hastanede kalış süresi ve böbrek fonksiyonlarının daha iyi korunması ile ilişkili olduğu bildirilmiştir. Ancak, Avrupa Üroloji kılavuzu bu tekniği halen deneysel bir tedavi yöntemi olarak kabul etmektedir.
Thermal ablation techniques are increasingly preferred in the treatment of small renal masses (SRMs). While traditional methods such as radiofrequency ablation (RFA) and cryoablation (CA) show limited efficacy in tumors larger than 3-4 cm, microwave ablation (MDA) stands out as a promising new alternative. Utilizing frequencies of 900 MHz and above, MDA agitates water molecules to generate friction and heat, causing cell death through coagulation necrosis. The technique offers several theoretical advantages, including higher intratumoral temperatures, larger ablation volumes, faster procedure times, and reduced susceptibility to perfusion-mediated heat-sink effects. Preliminary and clinical studies demonstrate that MDA is a safe and effective option for stage T1a and T1b tumors, as well as for patients with a solitary kidney. Compared to surgical options like radical or partial nephrectomy, MDA provides comparable oncological outcomes while offering lower blood loss, shorter hospital stays, and better preservation of renal function. Nevertheless, the European Association of Urology guidelines still categorize MDA as an experimental treatment modality.
Referanslar
Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renalparenchymal neoplasms: further observations on growth. Radi-ology 1995;197:589-97.
Homma Y, Kawabe K, Kitamura T, Nishimura Y, Shinohara M, Kondo Y, Saito I, Minowada S, Asakage Y. Increased incidental detection and reduced mortality in renal cancer--recent retrospective analysis at eight institutions. Int J Urol. 1995 May;2(2):77-80.
Iguchi T, Hiraki T, Tomita K, Gobara H, Fujiwara H, Sakurai J, Matsui Y, Kanazawa S. Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma. Diagn Interv Imaging. 2016 Nov;97(11):1159-64.
Cornelis F, Balageas P, Le Bras Y, Rigou G, Boutault JR, Bouzgarrou M, Grenier N. Radiologically-guided thermal ablation of renal tumours. Diagn Interv Imaging. 2012 Apr;93(4):246-61.
Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hospital Reports 1894–1895;4:297–350.
Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174:323–31.
Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities— part 2. J Vasc Interv Radiol 2001;12:1135–48.
de Baere T, Deschamps F. New tumor ablation techniques forcancer treatment (microwave, electroporation). Diagn IntervImaging 2014;95:677-82.
Seror O. Ablative therapies: advantages and disadvantages ofradiofrequency, cryotherapy, microwave and electroporationmethods, or how to choose the right method for an individualpatient? Diagn Interv Imaging 2015;96:617-24.
Ljungberg B, Albiges L, Bensalah K, Bex A, Giles R, Hora M, et al. EAU Guidelines on Renal Cell Carcinoma 2018. Euro Urol. 2018;29(5):451–8.
Skinner MG, Iizuka MN, Kolios MC, Sherar MD. A theoretical comparison of energy sources—microwave, ultrasound and laser-for interstitial thermal therapy. Phys Med Biol 1998;43:3535–47.
Stauffer PR, Rossetto F, Prakash M, Neuman DG, Lee T. Phantom and animal tissues for modelling the electrical properties of human liver. Int J Hyperthermia 2003;19:89–101.
Wright AS, Lee FT Jr, Mahvi DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003;10:275–83.
Shock SA, Meredith K, Warner TF, Sampson LA, Wright AS, Winter TC 3rd, Mahvi DM, Fine JP, Lee FT Jr. Microwave ablation with loop antenna: in vivo porcine liver model. Radiology. 2004 Apr;231(1):143-9.
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005 Oct;25 Suppl 1:S69-83.
Brace CL. Radiofrequency and microwave ablation of the liver,lung, kidney, and bone: what are the differences? Curr ProblDiagn Radiol 2009;38:135-43.
Stuchly MA, Athey TW, Stuchly SS, Samaras GM, Taylor G.Dielectric properties of animal tissues in vivo at frequencies10 MHz-1 GHz. Bioelectromagnetics 1981;2:93-103.
Cornelis FH, Marcelin C, Bernhard JC. Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results. Diagn Interv Imaging. 2017 Apr;98(4):287-97.
Wright AS, Lee FT Jr, Mahvi DM. Microwave ablation of hepatic tumors: results of a phase I clinical trial. (abstr) Ann Surg Oncol 2003; 56:78A.
Wright AS, Mahvi DM, Haemmerich DG, Lee FT Jr. Minimally invasive approaches in management of hepatic tumors. Surg Technol Int 2003; 11:144–53
Seki S, Sakaguchi H, Kadoya H, Morikawa H, Habu D, Nishiguchi S, Shiomi S, Kitada T, Kuroki T. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma. Endoscopy. 2000 Aug;32(8):591-7.
Midorikawa T, Kumada K, Kikuchi H, Ishibashi K, Yagi H, Nagasaki H, Nemoto H, Saitoh M, Nakano H, Yamaguchi M, Koh Y, Sakai H, Yoshizawa Y, Sanada Y, Yoshiba M. Microwave coagulation therapy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2000;7(3):252-9.
Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, Wang XD, Xin H, Li S. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. AJR Am J Roentgenol. 1998 Aug;171(2):449-54.
Izumi N, Asahina Y, Noguchi O, Uchihara M, Kanazawa N, Itakura J, Himeno Y, Miyake S, Sakai T, Enomoto N. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer. 2001 Mar 1;91(5):949-56.
Carrafiello G, Laganà D, Mangini M, Fontana F, Dionigi G, Boni L, Rovera F, Cuffari S, Fugazzola C. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 2008;6 Suppl 1:S65-9.
Clark PE, Woodruff RD, Zagoria RJ, Hall MC. Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study. AJR Am J Roentgenol. 2007 May;188(5):1212-4.
Carrafiello G, Mangini M, Fontana F, Recaldini C, Piacentino F, Pellegrino C, Laganà D, Cuffari S, Marconi A, Fugazzola C. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience. Cardiovasc Intervent Radiol. 2010 Apr;33(2):367-74.
Bai J, Hu Z, Guan W, Zhuang Q, Wang S, Liu J, Ye Z. Initial experience with retroperitoneoscopic microwave ablation of clinical T(1a) renal tumors. J Endourol. 2010 Dec;24(12):2017-22.
Castle SM, Salas N, Leveillee RJ. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up. Urology. 2011 Apr;77(4):792-7.
Muto G, Castelli E, Migliari R, D'Urso L, Coppola P, Collura D. Laparoscopic microwave ablation and enucleation of small renal masses: preliminary experience. Eur Urol. 2011 Jul;60(1):173-6
Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Wang XH. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 2012 Jun;263(3):900-8. doi: 10.1148/radiol.12111209.
Moreland AJ, Ziemlewicz TJ, Best SL, Hinshaw JL, Lubner MG, Alexander ML, Brace CL, Kitchin DR, Hedican SP, Nakada SY, Lee FT Jr, Abel EJ. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation. J Endourol. 2014 Sep;28(9):1046-52.
Guo J, Arellano RS. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors. AJR Am J Roentgenol. 2021 Jan;216(1):117-24.
Chan P, Vélasco S, Vesselle G, Boucebci S, Herpe G, Debaene B, Ingrand P, Irani J, Tasu JP. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up. Clin Radiol. 2017 Sep;72(9):786-92.
Ierardi AM, Puliti A, Angileri SA, Petrillo M, Duka E, Floridi C, Lecchi M, Carrafiello G. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications. Med Oncol. 2017 May;34(5):97.
Klapperich ME, Abel EJ, Ziemlewicz TJ, Best S, Lubner MG, Nakada SY, Hinshaw JL, Brace CL, Lee FT Jr, Wells SA. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study. Radiology. 2017 Jul;284(1):272-280.
Li X, Liang P, Yu J, Yu XL, Liu FY, Cheng ZG, Han ZY. Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma. Radiol Oncol. 2013 Oct 8;47(4):398-404.
B. M. Aarts, W. Prevoo. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma Cardiovasc Intervent Radiol (2020) 43:1025–33.
John JB, Anderson M, Dutton T, Stott M, Crundwell M, Llewelyn R, Gemmell A, Bufacchi R, Spiers A, Campain N. Percutaneous microwave ablation of renal masses in a UK cohort. BJU Int. 2021 Apr;127(4):486-94.
Shane A. Wells,1 Karen M. Wheeler Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Abdom Radiol (2016) 41:1203–11.
Lin Y, Liang P, Yu XL, Yu J, Cheng ZG, Han ZY, Liu FY. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney. Urology. 2014 Feb;83(2):357-63.
Meng H, Yang H, Jia H, Pan F, Dong X, Liu B, Li C. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney. Int J Hyperthermia. 2021;38(1):691-5.
Yu J, Zhang G, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X, Dong J, Li QY, Mu MJ, Li X. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma. Abdom Imaging. 2015 Oct;40(8):3248-56.
Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X, Dong J, Mu MJ, Li X, Wang XH. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology. 2014 Mar;270(3):880-7.
Guan W, Bai J, Liu J, Wang S, Zhuang Q, Ye Z, Hu Z. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012 Sep 1;106(3):316-21.
Yu J, Zhang X, Liu H, Zhang R, Yu X, Cheng Z, Han Z, Liu F, Hao G, Mu MJ, Liang P. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients. Radiology. 2020 Mar;294(3):698-706.
Shapiro DD, Wells SA, Best SL, Hedican SP, Ziemlewicz TJ, Lubner MG, Hinshaw JL, Lee FT Jr, Jarrard DF, Richards KA, Downs TM, Allen GO, Nakada SY, Abel EJ. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery. Urology. 2020 Jan;135:88-94.
Zhong J, Wah TM. Renal ablation: current management strategies and controversies. Chin Clin Oncol. 2019 Dec;8(6):63.
Zhou W, Herwald SE, McCarthy C, Uppot RN, Arellano RS. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes. J Vasc Interv Radiol. 2019 Jul;30(7):1035-42.
Abboud SE, Patel T, Soriano S, Giesler J, Alvarado N, Kang P. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center. Curr Probl Diagn Radiol. 2018 Mar-Apr;47(2):98-102.
Zhou W, Arellano RS. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation. J Vasc Interv Radiol. 2018 Jul;29(7):943-51.
Martin J, Athreya S. Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome? Diagn Interv Radiol. 2013 Nov-Dec;19(6):501-7.
